I am a corporate attorney who advises clients on a wide range of business and legal issues.

Rui is an experienced attorney with deep expertise in a wide range of matters, including mergers and acquisitions, joint ventures, IPOs, restructuring, technology transactions and alliances and legal due diligence. She brings extensive international experience, working in a variety of industries and fields in China for the last decade. While there, she served global, publicly traded pharmaceutical companies as in-house counsel and with domestic and international law firms.

Rui focuses her practice on transactional and general corporate matters, as well as international corporate affairs, specifically in the life science industry and cross-border transactions.

Services

Business & Corporate

Our business is business–your business. We offer vast experience in a full array of corporate legal services.

Credentials

Education

  • University of Wisconsin-Madison Law School, 2013
    • LL.M
  • East China University of Politics and Law, 2007
    • LL.B

Memberships

  • Certificate of Accounting Professional (P.R.C)

Admissions

  • California, 2022
  • Michigan, 2020
  • China (Inactive)

Professional Achievements

  • Best LawyersOnes to Watch in America, 2024
  • Michigan Super Lawyers, "Rising Stars," 2023

Experience

Representative Matters

  • Advised several Hong Kong-based and other international food and beverage companies on their Chinese operations and rendered assistance in establishing retail outlets and licensing issues.

    Edit
  • Advised an Australian agribusiness on its strategic investment in a Changsha (PRC) based distribution company and intellectual property registrations.

    Edit
  • Acted for a NASDAQ-listed greenhouse vegetable producer regarding its two-round pre-IPO financing of $80 million.

    Edit
  • Advised three Chinese companies regarding their IPOs on the main board of the Frankfurt Stock Exchange.

    Edit
  • Provided corporate legal advice on genomics restructuring of Next Code.

    Edit
  • Managed biologics assets restructuring for the listing of WuXi Biologies, Inc. (Cayman) on the Hong Kong Stock Exchange raising $511 million.

    Edit
  • Assisted in the creation of LabNetwork, a global e-commerce platform for research chemicals and compounds. 

    Edit